https://www.globenewswire.com/fr/news-release/2025/06/10/3097181/0/en/BioAegis-Therapeutics-Announces-US-Navy-Contract-to-Support-Phase-2-Study-of-Recombinant-Human-Gelsolin-for-Inflammasome-Driven-Decompression-Sickness-DCS.html
BioAegis Therapeutics Announces US Navy Contract to Support
Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the...
us navytherapeuticsannouncescontractsupport
https://www.globenewswire.com/fr/news-release/2020/08/05/2073785/0/en/BioAegis-Therapeutics-Initiates-Phase-2-Clinical-Trial-of-Its-Inflammation-Regulator-Gelsolin-for-COVID-19-Treatment.html
BioAegis Therapeutics Initiates Phase 2 Clinical Trial of
MORRISTOWN, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious,...
clinical trialtherapeuticsinitiatesphase